OTC drug advertising scope must extend to more therapeutic groups.

The pharmaceutical industry claimed that the public advertising controls over the OTC drugs should be eased more to other therapeutic groups in view of saving the NHI finance and boosting more OTC drug consumptions.

The industry stressed that a drug proven of its safety and efficacy with minor side effects should put under the category of public advertising items. Furthermore, the public ad...